scholarly journals Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

2016 ◽  
pp. 29 ◽  
Author(s):  
Tohru Ohnuma ◽  
Aiko Toda ◽  
Ayako Kimoto ◽  
Yuto Takebayashi ◽  
Ryoko Higashiyama ◽  
...  
Keyword(s):  
Pilot Study ◽  
Medium Chain Triglyceride ◽  
Japanese Patients ◽  
Open Label ◽  
Medical Food ◽  
Medium Chain

scholarly journals The effects of a unique medium chain triglyceride complex on migraine symptoms: A beta pilot study

2020 ◽  
Vol 8 (3) ◽  
pp. 175-183
Author(s):  
Neil Ernest Wolkodoff ◽  
Gerald Martin Haase ◽  
Robert Alexander Firger
Keyword(s):  
Pilot Study ◽  
Controlled Trial ◽  
Medium Chain Triglyceride ◽  
Electronic Record ◽  
Baseline Period ◽  
High Concentration ◽  
Open Label ◽  
Potential Relief ◽  
Record Keeping ◽  
Medium Chain

Purpose: Migraine headaches are among the most common worldwide medical issues, and various drug therapies only offer limited relief. Medium chain triglyceride (MCT) oil has demonstrated clinical benefits in multiple domains, from enhanced overall energy to increased brain function. This pilot study investigated the potential relief provided from a unique proprietary formulation, including a high concentration MCT-containing blend on migraine frequency, duration, and severity over 30 days. Methods: Fourteen (n=14) chronic migraine sufferers (migraineurs) were prospectively selected to participate in the open-label trial of this patented complex. Participants were instructed to maintain a consistent lifestyle, health factors, and medications while consuming the study compound. Because of the current Corona virus pandemic, the original paper version of the migraine survey was converted to an electronic response form to allow subjects increased safety in rating episodes and symptoms. Results: Overall, the subjects reduced the number of migraine episodes by 39% from the baseline period compared to after 30 days of using the supplement. The average episode duration decreased from 388 minutes to 152 minutes, a 61% reduction. Days/events missed due to migraine severity or complications were reduced from five per month to two per month, a decrease of 60%. A combined measure of specific symptoms also decreased according to subject rating, by an average of 32%. Conclusion: In this beta pilot study, consumption of a high concentration MCT complex produced significant improvements in migraine symptoms in the three significant episode realms of frequency, duration, and lost days due to dysfunction. In addition, migraine symptom surveys can be converted to electronic record keeping, a benefit for both the patient and the clinician. These outcomes have provided further impetus to pursue a rigorous study of specific MCT products to reduce migraine symptoms. A formal confirmatory placebo-controlled trial has been initiated.

Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open-label pilot study

2015 ◽  
Vol 41 (10) ◽  
pp. 1584-1590 ◽  
Author(s):  
Takashi Takeda ◽  
Akiko Kondo ◽  
Shoko Koga ◽  
Jun Hayakawa ◽  
Kenichi Hayakawa ◽  
...  
Keyword(s):  
Pilot Study ◽  
Japanese Patients ◽  
Open Label ◽  
Premenstrual Symptoms

scholarly journals Cognition may improve with medium‐chain triglyceride oil supplementation: A pilot study

2021 ◽  
Vol 17 (S6) ◽  
Author(s):  
Heidi L Hillebrandt ◽  
Cintia B Dias ◽  
Edward S Barin ◽  
Pratishtha Chatterjee ◽  
Tejal M Shah ◽  
...  
Keyword(s):  
Pilot Study ◽  
Medium Chain Triglyceride ◽  
Medium Chain
Sign in / Sign up

Export Citation Format

Share Document